[go: up one dir, main page]

NO20071238L - Fremgangsmater for leging av skader ved human IL-18 administrering - Google Patents

Fremgangsmater for leging av skader ved human IL-18 administrering

Info

Publication number
NO20071238L
NO20071238L NO20071238A NO20071238A NO20071238L NO 20071238 L NO20071238 L NO 20071238L NO 20071238 A NO20071238 A NO 20071238A NO 20071238 A NO20071238 A NO 20071238A NO 20071238 L NO20071238 L NO 20071238L
Authority
NO
Norway
Prior art keywords
human
administration
methods
healing damage
healing
Prior art date
Application number
NO20071238A
Other languages
English (en)
Inventor
Judithann Lee
Kimberly A Dede
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20071238L publication Critical patent/NO20071238L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen er generelt relatert til anvendelsen av humant IL- 18, også kjent som interferon-?-induserende faktor (IGIF), i behandlingen av hudskader, kirurgiske skader, leggssår, diabetessår, gastrointestinal mukositt, oral mukositt og lungeskader.
NO20071238A 2004-08-20 2007-03-07 Fremgangsmater for leging av skader ved human IL-18 administrering NO20071238L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60301204P 2004-08-20 2004-08-20
PCT/US2005/029358 WO2006023623A2 (en) 2004-08-20 2005-08-18 Methods of healing wounds by administering human il-18

Publications (1)

Publication Number Publication Date
NO20071238L true NO20071238L (no) 2007-05-14

Family

ID=35968167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071238A NO20071238L (no) 2004-08-20 2007-03-07 Fremgangsmater for leging av skader ved human IL-18 administrering

Country Status (23)

Country Link
US (1) US7595039B2 (no)
EP (2) EP1793859B1 (no)
JP (1) JP4912306B2 (no)
KR (1) KR20070050924A (no)
CN (1) CN101039696B (no)
AT (2) ATE526057T1 (no)
AU (1) AU2005277404A1 (no)
BR (1) BRPI0514445A (no)
CA (1) CA2577777A1 (no)
CY (1) CY1108991T1 (no)
DE (1) DE602005013542D1 (no)
DK (1) DK1793859T3 (no)
ES (2) ES2322605T3 (no)
IL (1) IL181286A0 (no)
MX (1) MX2007002134A (no)
NO (1) NO20071238L (no)
NZ (1) NZ552837A (no)
PL (1) PL1793859T3 (no)
PT (1) PT1793859E (no)
RU (1) RU2387455C2 (no)
SI (1) SI1793859T1 (no)
WO (1) WO2006023623A2 (no)
ZA (1) ZA200700524B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120011898A (ko) * 2000-02-10 2012-02-08 아보트 러보러터리즈 사람 인터류킨-１８에 결합하는 항체 및 이를 제조하고 사용하는 방법
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
RU2423971C1 (ru) * 2010-06-01 2011-07-20 Закрытое акционерное общество "Биологические исследования и системы" Способ ускорения заживления кожных повреждений, вызванных денервацией и нарушением кровоснабжения
CA2839261A1 (en) 2011-06-13 2012-12-20 Neumedicines, Inc. Mitigation of cutaneous injury with il-12
MX385868B (es) 2013-09-05 2025-03-18 Ab2 Bio Sa Proteina de union a interleucina 18 (il-18bp) en enfermedades inflamatorias.
CN107660150B (zh) 2015-03-05 2023-10-24 Ab2生物股份有限公司 Il-18结合蛋白(il-18bp)和抗体在炎性疾病中
IL272635B2 (en) 2017-09-06 2024-02-01 Univ Yale Interleukin-18 variants and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69519454T2 (de) 1994-07-14 2001-05-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen
TW581771B (en) 1994-11-15 2004-04-01 Hayashibara Biochem Lab Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US5680795A (en) 1995-07-05 1997-10-28 Norco Inc. Mechanical drive assembly incorporating counter-spring biassed radially-adjustable rollers
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド
DE69819563T2 (de) * 1998-03-07 2004-09-16 Daewoong Pharmaceutical Co., Ltd., Sungnam Topische zusammensetzung enthaltend menschlichen epidermalen wachstumsfaktor
TWI227136B (en) * 1998-05-21 2005-02-01 Smithkline Beecham Corp Novel pharmaceutical composition for the prevention and/or treatment of cancer
EP1296707A4 (en) * 2000-06-02 2004-03-17 Smithkline Beecham Corp METHODS OF TREATING VIRAL DISEASES WITH IL-18 AND IL-18 COMBINATIONS
HUP0501002A3 (en) * 2000-06-15 2010-01-28 Smithkline Beecham Corp Method for preparing a physiologically active il-18 polypeptide
US7098373B2 (en) * 2001-07-12 2006-08-29 Hitoshi Mizutani IL-18 transgenic animal
DK1545587T3 (da) * 2002-09-16 2011-05-09 Agennix Inc Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
EP1572228A4 (en) * 2002-09-19 2009-03-04 Centocor Inc METHOD FOR THE INTRODUCTION OF THE TREATMENT OF DENDRITIC CELLS AND ITS USES
US20050075277A1 (en) * 2003-07-10 2005-04-07 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects

Also Published As

Publication number Publication date
ATE426410T1 (de) 2009-04-15
SI1793859T1 (sl) 2009-06-30
CA2577777A1 (en) 2006-03-02
EP2161032A3 (en) 2010-07-28
US7595039B2 (en) 2009-09-29
NZ552837A (en) 2009-09-25
EP1793859B1 (en) 2009-03-25
ZA200700524B (en) 2008-05-28
EP1793859A2 (en) 2007-06-13
JP2008510709A (ja) 2008-04-10
BRPI0514445A (pt) 2008-06-10
EP2161032B1 (en) 2011-09-28
PT1793859E (pt) 2009-06-04
PL1793859T3 (pl) 2009-08-31
HK1109054A1 (en) 2008-05-30
DE602005013542D1 (de) 2009-05-07
RU2387455C2 (ru) 2010-04-27
EP2161032A2 (en) 2010-03-10
CY1108991T1 (el) 2014-07-02
KR20070050924A (ko) 2007-05-16
AU2005277404A1 (en) 2006-03-02
RU2007110166A (ru) 2008-09-27
EP1793859A4 (en) 2008-02-13
JP4912306B2 (ja) 2012-04-11
MX2007002134A (es) 2007-09-14
DK1793859T3 (da) 2009-06-22
CN101039696B (zh) 2011-08-17
CN101039696A (zh) 2007-09-19
ES2322605T3 (es) 2009-06-23
ES2372728T3 (es) 2012-01-25
WO2006023623A2 (en) 2006-03-02
WO2006023623A3 (en) 2006-08-24
IL181286A0 (en) 2007-07-04
ATE526057T1 (de) 2011-10-15
US20060039892A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
NO20071238L (no) Fremgangsmater for leging av skader ved human IL-18 administrering
NO20053742L (no) Tri (cyclo)-substituerte amidforbindelser
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
CY1108992T1 (el) Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
MY129079A (en) Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
BRPI0418157A (pt) terapêutica de tumores alogênicos
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
AR045865A1 (es) El uso de un polifenol para el tratamiento de una lesion cancerosa o pre-cancerosa de la piel
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
DE602004010691D1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
ATE535237T1 (de) Verwendung von fts zur behandlung von malignen erkrankungen
DE502004011874D1 (de) Flupirtine-präparat zur behandlung von neurodegeneetes mellitus
DE50310383D1 (de) Humanes chondroosteomodulin (tig2), herstellung und verwendung zur behandlung oder diagnose von knochen- und knorpelerkrankungen, fettsucht sowie entzündlichen erkrankungen und hauterkrankungen
ATE468133T1 (de) Verwendung von g-csf als zusätzliche behandlung in die wiederherstellung von bindegewebe
DE602004021915D1 (de) Verwendung der cinchonapflanze zur herstellung eines medikamentes zur stimulierung der angiogenese
PL1818052T3 (pl) Zastosowanie formoterolu w profilaktycznym i/lub terapeutycznym leczeniu wyniszczenia mięśniowego i/lub zespołu wyniszczenia, związanych ze stanami katabolicznymi w przebiegu niektórych chorób, takich jak nowotwory, AIDS, zakażenia, cukrzyca i inne
PE20030337A1 (es) Indan-1-onas sustituidas en c2 y sus derivados, procedimiento para su preparacion y su utilizacion como medicamentos
ATE532512T1 (de) Isoniazid-vermittelte heilung von wunden und geschwüren
ATE425765T1 (de) Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen
TR200301800A2 (tr) Bir farmasötik terkip.
MX2007007304A (es) Aceite regenerador celular.
YU17703A (sh) Nova farmaceutska kompozicija za primenu na koži
FI20021180A0 (fi) Lääketieteellisen tutkimus- ja käsittelypöydän jatkesovitelma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application